Molecular Analysis for Therapy Choice (MATCH)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02465060

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:27:58.682286+00:00

Published At

2026-04-13T00:00:00+00:00

Record Updated At

2026-04-13

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Advanced Lymphoma", "Advanced Malignant Solid Neoplasm", "Bladder Carcinoma", "Breast Carcinoma", "Cervical Carcinoma", "Colon Carcinoma", "Colorectal Carcinoma", "Endometrial Carcinoma", "Esophageal Carcinoma", "Exocrine Pancreas Carcinoma", "Gastric Carcinoma", "Glioma", "Head and Neck Carcinoma", "Hematopoietic and Lymphoid Cell Neoplasm", "Kidney Carcinoma", "Liver Carcinoma", "Lung Carcinoma", "Lymphoma", "Malignant Uterine Corpus Neoplasm", "Malignant Uterine Neoplasm", "Melanoma", "Multiple Myeloma", "Ovarian Carcinoma", "Prostate Carcinoma", "Rectal Carcinoma", "Recurrent Bladder Carcinoma", "Recurrent Breast Carcinoma", "Recurrent Cervical Carcinoma", "Recurrent Colon Carcinoma", "Recurrent Colorectal Carcinoma", "Recurrent Esophageal Carcinoma", "Recurrent Gastric Carcinoma", "Recurrent Glioma", "Recurrent Head and Neck Carcinoma", "Recurrent Liver Carcinoma", "Recurrent Lung Carcinoma", "Recurrent Lymphoma", "Recurrent Malignant Solid Neoplasm", "Recurrent Malignant Uterine Corpus Neoplasm", "Recurrent Melanoma", "Recurrent Multiple Myeloma", "Recurrent Ovarian Carcinoma", "Recurrent Pancreatic Carcinoma", "Recurrent Prostate Carcinoma", "Recurrent Rectal Carcinoma", "Recurrent Skin Carcinoma", "Recurrent Thyroid Gland Carcinoma", "Refractory Lymphoma", "Refractory Malignant Solid Neoplasm", "Refractory Multiple Myeloma", "Skin Carcinoma", "Thyroid Gland Carcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-13"

protocolSection.identificationModule.nctId

"NCT02465060"

protocolSection.identificationModule.officialTitle

"Molecular Analysis for Therapy Choice (MATCH)"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Advanced Lymphoma (protocolSection.conditionsModule.conditions)
• Advanced Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Bladder Carcinoma (protocolSection.conditionsModule.conditions)
• Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Cervical Carcinoma (protocolSection.conditionsModule.conditions)
• Colon Carcinoma (protocolSection.conditionsModule.conditions)
• Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
• Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
• Esophageal Carcinoma (protocolSection.conditionsModule.conditions)
• Exocrine Pancreas Carcinoma (protocolSection.conditionsModule.conditions)
• Gastric Carcinoma (protocolSection.conditionsModule.conditions)
• Glioma (protocolSection.conditionsModule.conditions)
• Head and Neck Carcinoma (protocolSection.conditionsModule.conditions)
• Hematopoietic and Lymphoid Cell Neoplasm (protocolSection.conditionsModule.conditions)
• Kidney Carcinoma (protocolSection.conditionsModule.conditions)
• Liver Carcinoma (protocolSection.conditionsModule.conditions)
• Lung Carcinoma (protocolSection.conditionsModule.conditions)
• Lymphoma (protocolSection.conditionsModule.conditions)
• Malignant Uterine Corpus Neoplasm (protocolSection.conditionsModule.conditions)
• Malignant Uterine Neoplasm (protocolSection.conditionsModule.conditions)
• Melanoma (protocolSection.conditionsModule.conditions)
• Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
• Prostate Carcinoma (protocolSection.conditionsModule.conditions)
• Rectal Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Bladder Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Cervical Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Colon Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Esophageal Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Gastric Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Glioma (protocolSection.conditionsModule.conditions)
• Recurrent Head and Neck Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Liver Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Lung Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Recurrent Malignant Uterine Corpus Neoplasm (protocolSection.conditionsModule.conditions)
• Recurrent Melanoma (protocolSection.conditionsModule.conditions)
• Recurrent Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Prostate Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Rectal Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Skin Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Thyroid Gland Carcinoma (protocolSection.conditionsModule.conditions)
• Refractory Lymphoma (protocolSection.conditionsModule.conditions)
• Refractory Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Refractory Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Skin Carcinoma (protocolSection.conditionsModule.conditions)
• Thyroid Gland Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.